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Background: Sex determining factor (SRY) located on the short arm of the Y chromosome, plays an important role
in initiating male sex determination, resulting in development of testicular tissue. Presence of the SRY gene in
females results in XY sex reversal and increased risk of gonadal germ cell tumours if the karyotype also includes
the so-called GonadoBlastoma on the Y chromosome (GBY) region. The majority of mutations within the SRY gene
are de novo affecting only a single individual in the family. The mutations within the high-mobility group (HMG)
region have the potential to affect its DNA binding activity.
Case Presentation: We performed G- and R-banding cytogenetic analysis of the patient and her family members
including her father. We also performed molecular genetic analysis of SRY gene. Cytogenetic analysis in the patient
(Turner Syndrome) revealed the mosaic karyotype as 45, X/46, XY (79%/21% respectively) while her father (milder
features with testicular dysgenesis syndrome) has a normal male karyotype (46, XY). Using molecular approach, we
screened the patient and her father for mutations in the SRY gene. Both patient and her father showed the same
deletion of cytosine within HMG box resulting in frame shift mutation (L94fsX180), the father in a mosaic pattern.
Histological examination of the gonads from the patient revealed the presence of gonadoblastoma formation,
while the father presented with oligoasthenozoospermia and a testicular seminoma. The frameshift mutation at
this codon is novel, and may result in a mutated SRY protein.
Conclusion: Our results suggest that lack of a second sex chromosome in majority cells of the patient may have
triggered the short stature and primary infertility, and the mutated SRY protein may be associated with the
development of gonadoblastoma. It is of importance to note that mosaic patients without a SRY mutation also
have a risk for malignant germ cell tumors.
Background
Turner Syndrome (TS) is a relatively common chromo-
somal disorder, caused by complete or partial X monos-
omy in some or all cells [1]. Almost half of the cases
have typical TS karyotype (45, X), whereas the remain-
ing cases either have a derivative sex chromosome in
the investigated cells or a mosaic karyotype, with the
second cell line having a normal or structurally rear-
ranged sex chromosome. TS with different karyotypes
have demonstrated the presence of a Y-chromosome or
Y- derived material in frequencies ranging from 4-61%
[2,3]. TS with mosaic 45, X/46, XY karyotype comprises
a phenotype spectrum of female (10-15%) having
mutated SRY and an increased risk for developing of
gonadoblastoma or dysgerminoma [4]. SRY is proven to
direct sex-determination pathway towards male develop-
ment [5,6]. This single exon gene is located on distal
part of the short arm of Y-chromosome spanning 3.8 kb
and encodes a 204 amino acid protein. SRY contains a
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in the middle of the protein [5,7]. The presence of
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latory role and it could work as a transcription factor.
Inactivating mutations in SRY gene cause failure to
develop testis and has been found to account for
approximately 15% of cases with gonadal dysgenesis and
XY sex-reversal [8,9]. However, a majority of these
patients may have mutations in other genes involved in
sex determination and differentiation (in term for devel-
opment of phenotypical sex characteristics) pathway or
in the regulatory elements of the SRY gene. To the best
of our knowledge more than 60 mutations have been
identified within open reading frame (ORF) of the SRY
gene, and majority of these are located within HMG
box, thus highlighting the vital and significant role of
this domain [10-12]. Less than 20 familial mutations in
SRY gene have been reported so for in the literature.
Here, we report a new point mutation in TS patient
who inherited the mutation from a phenotypically nor-
mal father. However, this male showed a form of Testi-
cular Dysgenesis Syndrome, i.e., oligoasthenozoospermia
and a testicular seminoma. To the best of our knowl-
edge no mutations at the above mentioned evolutionary
conserved codon have been reported previously in the
literature.
Case Presentation
Informed consent was obtained from the patient, her
family members and control individuals who partici-
pated in the present study. This study was approved by
the ethics as well as bio-safety committee of the hospital
and university.
Patient II-5
Patient II-5, a 23 years old female, with short stature,
ambiguous external genitalia and absence of pubertal
development was referred for cytogenetic analysis. Phy-
sical examination revealed her height as 145 cm (below
the fifth percentile). This patient showed multiple
Turner stigmata such as micrognathia, low-set ears,
high-arched palate, short and webbed neck, bilateral
cubitus valgus, low hair line, presence of Müllerian
structure, widely spaced nipples, nail dysplasia and mul-
tiple nevi. Sparse axillary and pubic hairs (Tanner stage
II) were observed, and there was no clitoromegaly.
Endocrinological studies demonstrated hypergonadotro-
pic hypogonadism (estradiol 12 pg/ml; LH 26.2 mIU/ml;
FSH 50.2 mIU/ml) as well as normal female concentra-
tions of testosterone and androstenedione. Sonographic
examination revealed a normal-sized uterus with a thin
endometrium and bilateral Müllerian derivatives. Ovar-
ies were not visible, but thickened structures resembling
streak gonads were present. Histological investigations
revealed only fibrous stromal tissue. Gonadoblastoma
was found in the streak gonads. Standard cytogenetic
analysis was performed and showed mosaic 45, X/46,
XY karyotype.
Patient I-1
He is the father of patient II-5 (Fig. 1). At the age of 53
yr, his height and weight were 1.79 m and 84 kg respec-
tively. The patient had normal secondary sex character-
istics. Orchidectomy was performed at the age of 48 yr
for the presence of pure testicular seminomatous tumor.
Histological examination of the gonad did not present
any signs of dysgenesis. At the time of examination, his
plasma testosterone (4.1 ng/ml; normal 2.5-9.5) and LH
(3.9 mU/ml; normal 2.2-5.8) and FSH levels (7.1 mU/ml;
normal 2-10) were within the normal range of an adult
male. Semen analysis showed signs of oligoasthenozoos-
permia (volume 1.4 ml; semen concentration 7.4 × 10
6/
ml; normal 20-40 × 10
6/ml; 37% motile sperm after
1 h). Reduced semen quantity and presence of testicular
cancer classifies him as the one with milder form of tes-
ticular dysgenesis syndrome.
Cytogenetic and Molecular analysis
Both G- and R-banding was performed on metaphase
spreads from peripheral blood of the patient, her sib-
lings and parents. Genomic DNA was extracted from
peripheral blood as well as gonadal tissue using DNA
isolation kit following manufacturers’ instructions. SRY
polymerase chain reaction amplifications, single strand
conformational polymorphism and sequencing were per-
formed as reported elsewhere [13]. The resulting PCR
products from I-1, II-5 were cloned and then 10 clones
were sequenced. In present study, cytogenetic analysis
has been done using G- and R-banding technique. The
patient (II-5) had a karyotype 45, X/46, XY (the ratio
being 79% and 21% respectively) and her father (I-1) a
normal male karyotype (46, XY, 100%). Patient II-5
showed altered level of estradiol, LH, FSH but with nor-
mal female concentration of testosterone and androste-
nedione. Both patient and her father showed altered
migration of PCR products in the SSCP assay (Fig 1A).
Both direct sequencing and sequencing from cloning
revealed a point mutation in HMG box of SRY gene in
the patient (Fig 1B). The sequence has a deletion of C
(cytosine) leading to frame shift mutation within the
open reading frame inside the highly conserved DNA-
binding motif-HMG box leading to a premature stop
codon. The mutation is described as L94fsX180.
Sequencing of both PCR products and cloning products
confirmed the presence of the same mutation as seen in
his daughter (II-5) however, the mutation is mosaic in
nature. It is clear from the pedigree as well that gonadal
mosaicism exits as indicated by the affected daughter
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the biological children of the father.
Normal male sex determination in mammals is tar-
geted by the SRY gene present on Y chromosome. Its
timing and expression is exquisitely regulated and must
probably reach the required threshold for testis forma-
tion in the developing embryo [10]. The patient
reported here have a mosaic 45, X/46, XY karyotype
with multiple Turner stigmata. We identified a new SRY
mutation in this patient. This mutation, leading to a
premature stop, may result in altered non-functional
protein as evident by the inability to develop male sex
organs. Sex determination during early embryonic stages
is characterized by complex interaction of various
genetic and non-genetic factors [14]. There is significant
evidence that SRY is essential for sex determination [5].
However, there are examples of SRY-negative individuals
who differentiate to males (20% XX males). Mutations
in SRY gene and presence of the dominant 45, X cell
line in the patient may have acted in a cumulative
Figure 1 Mutation(s) in the SRY gene in the affected family.( A )P o l y m e r a s ec h a i nr e a ction-SSCP analysis of SRY gene. Lane 1, SRY from
normal male control DNA (II-2); lanes 2 and 3: SRY with altered band from patient I-1 and II-5 respectively. The migration pattern from I-1 clearly
indicates that there are two different alleles that he shares with normal son (not shown) and affected daughter; (B) Pedigree of the affected
family also showing partial electropherograms of the mutation (deletion of C in the HMG box (helix 2) leading to a premature stop codon as
L94fsX180) identified in patient II-5 and her father (I-1). These results were obtained by sequencing of the amplification products after cloning.
Wild-type electropherogram identified in the normal brother (II-2) is also indicated. White symbols denote unaffected individuals where as black
symbols denote affected individuals. The arrow indicates the proband (II-5).
Shahid et al. BMC Medical Genetics 2010, 11:131
http://www.biomedcentral.com/1471-2350/11/131
Page 3 of 6manner to induce a cause-effect relationship. This may
account for non-masculinization in an otherwise origin-
ally XY embryo. Unequal distribution of two cell lines
as seen in this patient may have originated at the time
of implantation and their distribution into fetal and pla-
cental poles [15]. SRY protein belongs to the SOX
family of transcription factors characterized by HMG
domain having DNA binding and bending properties. It
has the ability to mediate protein-protein interactions
and contain signals for its nuclear import [16,17]. This
mutational change as reported here in this report may
have an electrostatic and hydrophobic interaction with
phosphate and sugars, respectively, of the DNA back-
bone. This alteration can result in specific orientation
and binding DNA bases in the major groove which can
thus totally or at least partially inhibit or reduce its
(SRY) interactions with DNA [18]. Deletion of cytosine
at codon 94 which is evolutionary conserved (Fig. 2) in
mammals has resulted in a nonsense frame shift muta-
tion (L94fsX180) within the HMG box, resulting in an
altered protein at the C terminus end. A phenotypical
female with mosaic 45, X/47, XYY karyotype and a
frame-shift mutation at codon 4 of SRY gene has been
reported in the literature [19]. It has been shown that
the mutant SRY may be assumed to induce a non-func-
tional SRY-coded protein that lacks DNA-binding motif.
Similarly there is another report that describes two
patients with 45, X/46, XY (mosaic karyotype) have a
missense mutation as S18N in the 5′ non-HMG box
region in blood as well as in streak gonads [20]. Muta-
tions in SRY gene are among known causes of 46, XY
pure gonadal dysgenesis (PGD). It has been generally
accepted that mutations in HMG box disrupt the gene’s
function. Likewise, mutations outside HMG box have
been reported in several patients with PGD, and one has
been detected in a 46, XY female with partial ovarian
function [20-22]. We analyzed DNA from her father
and found the similar mutation but in the mosaic condi-
tion in peripheral blood as well as in sperm DNA.
Transmission of this mutation from father to the
affected daughter and a wild type SRY sequence to the
normal son further provide the basis that this mutation
is present in the mosaic condition in father. The muta-
tion has resulted in a truncated SRY protein and hence,
could have altered its binding activity. The development
of normal male sex determination and differentiation
might be due to the presence of a transcript with wild
type SRY protein due to the mosaicism in the gonadal
tissue. It is quite possible that some mutational event(s)
might have occurred during the early embryonic life.
Our findings are further strengthened by other reports
of transmission of mutation from fertile fathers to their
XY daughters [14,23,24]. In the present study, the
patient also developed a bilateral gonadoblastoma, a
Figure 2 Alignment of HMG box sequences of SRY proteins from different mammalian species.P o s i t i o n9 4( s h o w ni nr e d )i sh i g h l y
conserved in different species (h: human; m: mouse; c: Chimpanzee; pc: Pygmy Chimpanzee; g: gorilla; py: Pongo; hl: Hylobates; b: Baboon and
cj: Calitrix).
Shahid et al. BMC Medical Genetics 2010, 11:131
http://www.biomedcentral.com/1471-2350/11/131
Page 4 of 6precursor lesion for malignant germ cell tumors in the
dysgenetic gonad is further supported by previous stu-
dies [25-29].
It is widely recognized that dysgenetic gonads, in some
cases related to SRY mutations develop gonadoblastoma
only in case GBY region is present in the genome. How-
ever, the molecular cause of gonadoblastoma formation
remains elusive. The failure of indifferent gonads to
develop during embryogenesis into testes ultimately
leads to a phenotypical female with delayed puberty and
amenorrhea. The GBY locus on Yq region is thought to
contain a proto-oncogene involved in the origin of these
tumors [30], for which TSPY is one of the likely candi-
dates, supported by strong expression of TSPY in CIS
and GB [31]. Normally, TSPY is expressed in spermato-
gonia of the adult testis and is believed to be related to
mitotic proliferation [32]. The presence of streak gonads
may be attributed to the invasion of primary genital
ridge by the 45, X cell line during early developmental
stages. Pubertal virilization in some TS patients repre-
sents an alarming sign of undetected Y-chromosome
positive cell lines that increase risk for developing gona-
doblastoma [19]. The mosaicism with Y-bearing cell line
(though with defective/mutated SRY)e v e na tl o wl e v e l s
formed during paternal meiosis and maternal non-dis-
junction during meiotic process may explain the
mechanisms underlying the abnormal sex development.
This is the second report that describes the mosaic fer-
tile father who shows milder features associated with
testicular dysgenesis syndrome and third report that
describes the patients with sex development disorders
(DSD) having mosaic mutation in SRY gene [24,33]. The
risk for the development of germ cell tumors is an
important factor to deal with the management of
patients having sex development disorders (DSD) [34].
To our knowledge this is the first report that describes
the SRY mutation in father who also shows oligoasthe-
nozoospermia and has developed testicular seminoma.
Both oligoasthenozoospermia and testicular cancer com-
prises the milder form of underlying entity associated
with Testicular Dysgenesis syndrome (TDS) which can
be caused by genetic and/or environmental factors.
However, till date no specific causes of this entity have
been identified. It may be possible that insufficient
androgen production during the fetal testis developmen-
tal stages may be associated with downstream entities
like TDS. It may be noted that the grand father
(deceased) of this patient (II-1) was associated with the
pesticide industry for quite a long time before the birth
of patient I-1. Therefore, it is possible that this environ-
mental exposure may also be responsible to certain
extent for this condition in I-1 that is inherited by the
patient II-5. The present and the previous published
paper [24] strengthens the role various genetic factors
along with the underlying mutations in SRY gene play in
abnormal sex development disorders, related to malig-
nant transformation of germ cells.
Conclusion
The present finding, especially the frameshift mutation
in the highly conserved codon in the HMG box of SRY
gene, further strengthen the functional importance of
this gene in the sex development. To the best of our
knowledge this is the first case (I-1) with the variant
form of TDS phenotype having mosaic mutation in SRY
gene. The frameshift mutation has been inherited by the
daughter (II-5). It is therefore, concluded that TS
patients must be analysed both by conventional cytoge-
netic and molecular genetics approaches to rule out the
presence of the Y chromosome and/or the SRY gene, as
well as the GBY region.
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